AT
LLY icon

Avalon Trust’s Eli Lilly LLY Stock Holding History

Avalon Trust’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$958K Sell
799
-50
-6% -$51.1K 0.06% 73
2026
Q1 		$781K Sell
849
-42
-5% -$42.6K 0.05% 75
2025
Q4 		$958K Sell
891
-75
-8% -$71.7K 0.06% 72
2025
Q3 		$737K Buy
966
+85
+10% +$63.3K 0.05% 81
2025
Q2 		$687K Hold
881
– – 0.05% 79
2025
Q1 		$728K Hold
881
– – 0.06% 81
2024
Q4 		$680K Buy
881
+11
+1% +$9.11K 0.05% 82
2024
Q3 		$771K Sell
870
-55
-6% -$49.4K 0.06% 77
2024
Q2 		$837K Sell
925
-15
-2% -$12K 0.07% 73
2024
Q1 		$731K Sell
940
-55
-6% -$39.1K 0.06% 78
2023
Q4 		$580K Buy
995
+267
+37% +$156K 0.05% 81
2023
Q3 		$391K Sell
728
-200
-22% -$103K 0.04% 86
2023
Q2 		$435K Buy
928
+605
+187% +$254K 0.04% 89
2023
Q1 		$111K Buy
+323
New +$109K 0.01% 151

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Avalon Trust's LLY Position: Q2 2026 in Review

Avalon Trust reduced its Eli Lilly (LLY) stake by 5.9% in Q2 2026, selling an estimated $51.1K and leaving 799 shares worth $958K. The position accounts for 0.06% of the portfolio, ranked #73.

Avalon Trust first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Avalon Trust held 799 shares of Eli Lilly worth $958K as of Q2 2026.
  • Avalon Trust sold 50 Eli Lilly shares in Q2 2026, an estimated $51.1K.
  • Eli Lilly made up 0.06% of Avalon Trust's portfolio in Q2 2026, its #73 holding.
  • Avalon Trust first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Avalon Trust's 13F filing for Q2 2026, filed 6 Aug 2026.